INDEPENDENT NEWS

Fyfe-chaired medicinal cannabis firm gets $6 mln investment

Published: Fri 26 Apr 2019 06:48 PM
Fyfe-chaired medicinal cannabis firm gets $6 mln investment
By Rebecca Howard
April 26 (BusinessDesk) - Pure Cann New Zealand, which counts former Air New Zealand boss Rob Fyfe as its executive chair, has secured $6 million from Australia's Cann Group for a 20 percent stake in the local medicinal cannabis company.
The investment will be made over stages with the initial 10 percent to be completed on or before Aug. 30 and a further 10 percent when New Zealand regulations come into force and Pure Cann's board approves the construction of its commercial cultivation facility.
The New Zealand government anticipates introducing new regulations, licensing requirements and quality standards governing medicinal cannabis usage by the end of this calendar year.
ASX-listed Cann Group has the option to increase its position to 30 percent.
Fyfe, currently Pure Cann's second largest shareholder with a 25.2 percent stake, said the move is a "pivotal moment for New Zealand's medicinal cannabis industry."
The strategic investment and a technical services agreement - which allows for mutual sharing of intellectual property - "ensure that Pure Cann is now fully funded and, more importantly, allows us to leverage the cultivation, production and technical leadership of Cann Group," the former Icebreaker chair said.
The move lets the two companies work together to "capitalise on the growing demand for medicinal cannabis in New Zealand and explore potential export opportunities as Pure Cann develops its own proposed cultivation and production facilities," said Cann Group chief executive Peter Crock.
Cann Group has established research and cultivation facilities in Melbourne and is looking to provide access to medicinal cannabis for Australian patients. Aurora Cannabis, one of Canada's largest listed medicinal cannabis companies, owns 22.9 percent of the Australian firm.
"Pure Cann is proposing to develop a range of organic medicinal cannabis products to serve patient needs in New Zealand and potential export markets," Crock said. "We are confident that Pure Cann will be able to leverage New Zealand's global reputation for development world leading premium and natural products."
(BusinessDesk)
BusinessDesk
Independent, Trustworthy New Zealand Business News
The Wellington-based BusinessDesk team provides a daily news feed for a serious business audience.
Contact BusinessDesk
Email:

Next in Business, Science, and Tech

Official Cash Rate unchanged at 1.5 percent
By: Reserve Bank
NZ economy loses momentum, risks tilted to downside - IMF
By: BusinessDesk
New pilot enables NZSA to track satellites launched from NZ
By: NZSA
NZ's living standards framework positive but has gaps
By: BusinessDesk
Safer banks and strengthened bank accountability
By: New Zealand Government
The RBNZ is renewing its approach to financial stability
By: Reserve Bank
IMF favours gradual bank capital hike
By: BusinessDesk
New Zealand: Staff Concluding Statement of Art IV Mission
By: International Monetary Fund
IMF confirms NZ economy slowing
By: New Zealand National Party
Egg Industry introduces first industry-led trace program
By: Egg Producers Federation
OECD joins KiwiBuild critics as 'reset' looms
By: BusinessDesk
Global trade crisis 'bad news' for open economies like NZ
By: BusinessDesk
NZ can improve well-being through better policymaking - OECD
By: OECD
Govt welcomes OECD report
By: New Zealand Government
PM's Post-Cabinet Press Conference 24 June 2019: Banking
By: The Scoop Team
View as: DESKTOP | MOBILEWe're in BETA! Send Feedback © Scoop Media